2018.2.27

Copenhagen CORS & Gifu Pharmaceutical University GRS Regulatory Science Student Forum

(The Maersk Tower - University of Copenhagen, Denmark)

​

2017.9.22

第5回岐阜イノベーション講演会（国際シンポジウム）

革新的糖尿病治療および治療薬開発を目指して

"Saving Pancreatic β cells from Cell Death in Type 2 Diabetes", Cnop M, (Professor, Université Libre de Bruxelles)
"Generation of Functional Mature Insulin-producing Cells from Induced Pluripotent Stem Cells", Kume S, (Professor, Tokyo Institute of Technology)
"Present and future of islet transplantation", Anazawa T, (Assist. Prof. Kyoto University Hospital)
"Experiences in development of bioengineered pancreatic islets", Doi M, (Director of laboratory, Otsuka Pharmaceutical Factory)
"Development and approval of regenerative medical products", Chikazawa K, (Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency)

2016.10.6

第4回岐阜イノベーション講演会（国際シンポジウム）

Vaccine Development for Future　今後のワクチン開発のあり方を考える

"Evaluation of Vaccines, Easy or difficult? Can we apply the Benefit Risk model?", Neels P, (Biomedical Sciences Department, University of Namur - Namur, Belgium)

"Effectiveness of Vaccine - from epidemiological perspective -", Kamiya H, (Infectious Disease Surveillance Center, National Institute of Infectious Diseases)

"HPV vaccination: is it worth it? - Establishing cost-effectiveness of HPV vaccination programs", Scuffham P, (Health Economics, Griffith University - Queensland, Australia)

"Deliver Innovative Recombinant Vaccines Expeditiously", Nakata F, (Director, UMN Pharma Inc.)

"Innovation and regulatory science for adjuvanted vaccines <New mechanism of action and potential biomarkers >", Ishii K, (Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition)

2016.8.26

特別セミナー　第6回　GRS塾

「薬価制度、調剤報酬と医療経済評価」，坂巻弘之，東京理科大学経営学部，医療経済研究機構　客員研究員

2016.2.26

Tufts CSDD & GPU GRS Joint Forum, (Tufts Center for the Study of Drug Development, USA)

2016.2.23

Georgetown University & Gifu Pharmaceutical University Regulatory Science Student Forum, (Georgetown University Center of Excellence in Regulatory Science and Innovation, USA)

2015.11.5

特別講義　第5回　GRS塾

「製薬会社はおもしろい：創薬と経営、私の経験」，竹中登一，岐阜薬科大学グローバル・レギュラトリー・サイエンス寄附講座　客員教授

2015.10.8

第3回岐阜イノベーション講演会（国際シンポジウム）

小児医薬品開発のために －過去、現在、未来－

"The paediatric regulatory framework for drug development in Europe", Brasseur D, (Paediatrician, Free University Brussels (ULB), Belgium)

"Current Situation of Pediatric Drug Development in Japan: What has been done and what needs to be done", Nakamura H, (Director for Clinical R & D, National Center for Child Health and Development, Japan),

"Actual cases of pediatric drug development - From a pharmaceutical industry's viewpoint", Osakabe M, (Head of R&D Division, Nobelpharma Co., Ltd.)

"For pediatric drug development - we can do 3D motion capture analysis -", Kato Z, (Structural Medicine, The United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University)

"Lessons from Pediatric Clinical Trials", Carroll K, (Research Scientist Navigator, Lurie Children's Hospital -Chicago, USA)

2015.9.2

特別講義　第4回　GRS塾

「消化器癌治療の最前線と将来の展望」，河合英，大阪医科大学　一般消化器外科　講師，上部消化管グループチーフ

2015.8.20

特別講義　第3回　GRS塾

「日本の新医薬品の承認審査と審査結果を用いたレギュラトリーサイエンス」，浅田隆太，岐阜大学医学部附属病院，先端医療・臨床研究推進センター　副センター長

2015.1.15

特別講義　第2回　GRS塾

「私の辿った創薬企業人生－創薬と経営－」，竹中登一，岐阜薬科大学グローバル・レギュラトリー・サイエンス寄附講座　客員教授

2014.10.10

第2回岐阜イノベーション講演会（国際シンポジウム）

アルツハイマー病新規治療薬の開発 －　FDAガイダンス、PMDA＆東大病院のレポート及びその他のイニシアティブの影響　－

"Novel Regulatory Science Research on the Drug Development for Alzheimer's Disease", Moritoyo T, (Associate Professor, Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital)

"An Overview of CSF Biomarkers of Alzheimer's Disease", Shoji M, (Professor, Department of Neurology, Hirosaki University Graduate School of Medicine)

"Use of Biomarker and Pharmacogenomics in New Drug Development for Alzheimer's Disease", Otsubo Y, (Ministry of Health, Labour and Welfare)

"From the Viewpoint of Japanese Pharma Companies", Iwai A, (Corporate Executive, Drug Discovery Research, Astellas Pharma Inc.)

"Global Trend of AD Clinical Development to Increase Probability of Positive Outcome", Sugino H, (Director, Innovative Indication, Regulatory Global Pharmaceutical Business, Otsuka Pharmaceutical, Copenhagen)

"The Changing Landscape for Bioinnovation: Economic Challenges in CNS Drug Development", Kaitin K, (Director and Professor, Tufts Center for the Study of Drug Development, Tufts University, USA)

2014.4.23

特別講義　第1回　GRS塾

「アベノミクス成長戦略における新たな医療分野の研究開発体制」，竹中登一，岐阜薬科大学グローバル・レギュラトリー・サイエンス寄附講座　客員教授